ω-3 Fatty acids for major depressive disorder in adults: an abridged Cochrane review (Q28076799)

1

0 references

Hannah Sallis

object named as

Hannah M Sallis

2

0 references

author name string

Rachel Perry

3

1 reference

Andrew R Ness

4

1 reference

language of work or name

1 reference

2 March 2016

7 references

13 March 2019

19 November 2019

21 September 2020

27 January 2021

28 April 2021

3 October 2022

6 references

19 November 2019

21 September 2020

27 January 2021

28 April 2021

3 October 2022

6

1 reference

issue

3

1 reference

page(s)

e010172

1 reference

Creative Commons Attribution-NonCommercial

copyright license

6 references

13 March 2019

19 November 2019

21 September 2020

27 January 2021

28 April 2021

3 October 2022

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Omega-3 fatty acids for depression in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

A rating scale for depression

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Measuring inconsistency in meta-analyses

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Quantifying heterogeneity in a meta-analysis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

20 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

20 March 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Development and validation of a geriatric depression screening scale: a preliminary report

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

A New Depression Scale Designed to be Sensitive to Change

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Imputing missing standard deviations in meta-analyses can provide accurate results

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

No role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

The efficacy of omega-3 supplementation for major depression: a randomized controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Is there a role for n-3 long-chain polyunsaturated fatty acids in the regulation of mood and behaviour? A review of the evidence to date from epidemiological studies, clinical studies and intervention trials.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Essential fatty acids and the brain

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Dietary polyunsaturated fatty acids and inflammatory mediator production

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

29 September 2017

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

The impact of long-chain n-3 polyunsaturated fatty acids on human health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

Fish consumption and major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

Fish consumption and self-reported physical and mental health status

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

Is low dietary intake of omega-3 fatty acids associated with depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

Risk of postpartum depression in relation to dietary fish and fat intake in Japan: the Osaka Maternal and Child Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

Depressed mood and n-3 polyunsaturated fatty acid intake from fish: non-linear or confounded association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

No clear evidence of an association between plasma concentrations of n-3 long-chain polyunsaturated fatty acids and depressed mood in a non-clinical population

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

Fish consumption in pregnancy and omega-3 status after birth are not associated with postnatal depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

Principles of and Procedures for Systematic Reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

Investigating and Dealing with Publication and Other Biases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

Eicosapentaenoic acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes mellitus: a randomized, double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double-blind, placebo-controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2015-010172

Short- and long-term repeatability of fatty acid composition of human plasma phospholipids and cholesterol esters. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4785331

Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients

27 November 2018

1 reference

12 December 2020

Fish consumption, depression, and suicidality in a general population

1 reference

12 December 2020

A Double-Blind, Placebo-Controlled Study of the Omega-3 Fatty Acid Docosahexaenoic Acid in the Treatment of Major Depression

1 reference

12 December 2020

Depression and adipose polyunsaturated fatty acids in an adolescent group

1 reference

12 December 2020

Depletion of docosahexaenoic acid in red blood cell membranes of depressive patients

1 reference

12 December 2020